Technical Analysis for VCNX - Vaccinex, Inc.

Grade Last Price % Change Price Change
grade C 4.9 0.00% 0.00
VCNX closed unchanged on Friday, February 15, 2019, on 45 percent of normal volume.

Earnings due: Feb 19

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical VCNX trend table...

Date Alert Name Type % Chg
Feb 15 20 DMA Resistance Bearish 0.00%
Feb 15 Doji - Bullish? Reversal 0.00%
Feb 14 Fell Below 20 DMA Bearish 0.00%
Feb 14 Outside Day Range Expansion 0.00%
Feb 13 20 DMA Support Bullish -2.87%
Feb 13 Narrow Range Bar Range Contraction -2.87%
Feb 13 Earnings Movers Other -2.87%
Feb 12 Narrow Range Bar Range Contraction -2.78%
Feb 12 Earnings Movers Other -2.78%
Feb 11 Narrow Range Bar Range Contraction 0.00%

Older signals for VCNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Biotechnology Health Cancer Biology Immunology Antibodies Immune System Monoclonal Antibodies Non Small Cell Lung Cancer Multiple Sclerosis Antibody Serious Diseases Melanoma Autoimmune Disorders Neurodegenerative Diseases Treatment Of Non Small Cell Lung Cancer Osteosarcoma Treatment Of Multiple Sclerosis Nsclc Seth Lederman Tolerx
Is VCNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.0
52 Week Low 3.32
Average Volume 4,441
200-Day Moving Average 0.0
50-Day Moving Average 4.6695
20-Day Moving Average 4.9418
10-Day Moving Average 4.8685
Average True Range 0.3469
ADX 20.92
+DI 36.9955
-DI 17.0923
Chandelier Exit (Long, 3 ATRs ) 4.7193
Chandelier Exit (Short, 3 ATRs ) 5.1407
Upper Bollinger Band 5.3793
Lower Bollinger Band 4.5043
Percent B (%b) 0.45
BandWidth 17.706099
MACD Line 0.0739
MACD Signal Line 0.0643
MACD Histogram 0.0096
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.28
Resistance 3 (R3) 5.32 5.23 5.21
Resistance 2 (R2) 5.23 5.14 5.21 5.19
Resistance 1 (R1) 5.07 5.08 5.03 5.03 5.17
Pivot Point 4.98 4.98 4.96 4.96 4.98
Support 1 (S1) 4.82 4.89 4.78 4.78 4.63
Support 2 (S2) 4.73 4.83 4.71 4.61
Support 3 (S3) 4.57 4.73 4.59
Support 4 (S4) 4.53